Written by LAURAN NEERGAARD
Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 — and if regulators agree, shots could begin within a matter of weeks.
Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities.
Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration.
Now the FDA will have to decide if there’s enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26.
One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody levels just as strong as teens and young adults get from regular-strength shots.
While kids are at lower risk of severe illness or death than older people, COVID-19 does sometimes kill children and cases in youngsters have skyrocketed as the extra-contagious delta variant has swept through the country
“It makes me very happy that I am helping other kids get the vaccine,” said Sebastian Prybol, 8, of Raleigh, North Carolina. He is enrolled in Pfizer’s study at Duke University and doesn’t yet know if he received the vaccine or dummy shots.
“We do want to make sure that it is absolutely safe for them,” said Sebastian’s mother, Britni Prybol. But she said she will be “overjoyed” if the FDA clears the vaccine.
Pfizer studied the lower dose in 2,268 volunteers ages 5 to 11, and has said there were no serious side effects. The study isn’t large enough to detect any extremely rare side effects, such as the heart inflammation that sometimes occurs after the second dose of the regular-strength vaccine, mostly in young men.
If the FDA authorizes emergency use of the kid-sized doses, there’s another hurdle before vaccinations in this age group can begin. Advisers to the Centers for Disease Control and Prevention will decide whether to recommend the shots for youngsters, and the CDC will make a final decision.
To avoid dosing mix-ups, Pfizer is planning to ship vials specially marked for pediatric use containing the lower dose.
Photo via AP Photo/Robert F. Bukaty.
Related Stories
‹

Moderna Sues Pfizer Over Patents Behind COVID-19 VaccineWritten by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]

UNC Football Offering Free Vaccines and Tickets to FansStarting with Saturday night’s game against Georgia State, UNC will be offering free COVID-19 vaccinations in front of Kenan Stadium. The vaccination tents will be located between gates 5 and 6 at the stadium, and will be operating from 4 p.m. to 7 p.m. before the game. The Moderna, Pfizer and Johnson & Johnson vaccines […]

Chansky's Notebook: To Vax Or NotCan athletes go unvaccinated and still be team players? This question has raged since COVID hit this country and eventually everyone had the choice to be vaccinated or not. For individuals, it is their absolute right to choose, although some organizations require it for them to keep working. The various professional players associations seem to […]

Shots for Tots: NC Begins COVID-19 Vaccines for Young ChildrenThe Centers for Disease Control recently approved both Moderna and Pfizer vaccines for children as young as six months. Locally, Orange County vaccines for the young age group are available starting Monday and by appointment only at the Southern Human Services Center in Chapel Hill.
![]()
Moderna Seeks FDA Authorization for 4th Dose of COVID ShotWritten by ZEKE MILLER Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults. The request is broader than rival pharmaceutical company Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors. In […]

Pfizer Says COVID Booster Offers Protection Against OmicronWritten by LAURAN NEERGAARD Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective. Pfizer and its partner BioNTech said that while two doses may not be protective enough to prevent infection, lab tests showed a booster […]

US Expands COVID Boosters to All Adults, Final Hurdle AheadWritten by LAURAN NEERGAARD and MATTHEW PERRONE U.S. regulators on Friday moved to open up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising coronavirus cases that may worsen with the holidays. Pfizer and Moderna announced the Food and Drug Administration’s decision after at least […]

US Gives Final Clearance to COVID-19 Shots for Kids 5 to 11U.S. health officials on Tuesday gave the final signoff to Pfizer’s kid-size COVID-19 shot, a milestone that opens a major expansion of the nation’s vaccination campaign to children as young as 5. The Food and Drug Administration already authorized the shots for children ages 5 to 11 — doses just a third of the amount […]

UNC Announces 2021-22 COVID Guidelines for Winter SportsAs the start of basketball season approaches, UNC has released its COVID guidelines for attendees at any winter sports event. The guidelines largely resemble those for fall sports. As all winter sports are played indoors, masks will be required at any event in the Dean Smith Center, Carmichael Arena or any other indoor venue. Attendees […]

Pfizer Asks US To Allow COVID Shots for Kids Ages 5 to 11Written by LAURAN NEERGAARD Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 — and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine […]
›
Comments on Chapelboro are moderated according to our Community Guidelines